Can-Fite BioPharma Ltd. (CANF)

Can-Fite BioPharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	4.83	4.28	2.98	4.39	8.27
Short-Term Investments	3.06	4.64	5	14.51	-
Trading Asset Securities	-	-	0.01	0.24	0.08
Cash & Short-Term Investments	7.89	8.92	7.99	19.14	8.34
Cash Growth	-11.60%	11.71%	-58.27%	129.40%	202.17%
Prepaid Expenses	1.02	0.91	1.12	0.88	1.04
Other Current Assets	0.08	0.08	0.05	0.05	0.02
Total Current Assets	8.98	9.91	9.16	20.07	9.4
Property, Plant & Equipment	0.14	0.08	0.13	0.19	0.12
Total Assets	9.12	9.99	9.28	20.25	9.52
Accounts Payable	0.62	0.43	0.9	0.95	0.56
Accrued Expenses	0.98	0.94	0.78	0.91	0.33
Current Portion of Leases	0.05	0.03	0.05	0.05	0.04
Current Unearned Revenue	0.41	0.62	0.78	0.82	0.33
Total Current Liabilities	2.05	2.02	2.5	2.73	1.27
Long-Term Leases	0.05	0.01	0.01	0.07	0.02
Long-Term Unearned Revenue	1.58	1.71	2.3	3.07	2.16
Total Liabilities	3.68	3.75	4.81	5.87	3.45
Common Stock	-	-	-	-	33.04
Additional Paid-In Capital	170.67	163.6	154.19	153.93	97.38
Retained Earnings	-166.36	-158.48	-150.85	-140.67	-125.47
Comprehensive Income & Other	1.13	1.13	1.13	1.13	1.13
Total Common Equity	5.44	6.24	4.47	14.38	6.07
Shareholders' Equity	5.44	6.24	4.47	14.38	6.07
Total Liabilities & Equity	9.12	9.99	9.28	20.25	9.52
Total Debt	0.1	0.04	0.06	0.12	0.07
Net Cash (Debt)	7.78	8.88	7.93	19.02	8.28
Net Cash Growth	-12.37%	12.08%	-58.32%	129.76%	208.12%
Net Cash Per Share	0.00	0.01	0.01	0.03	0.02
Filing Date Shares Outstanding	3,106	1,497	1,225	815.75	515.75
Total Common Shares Outstanding	2,983	1,360	815.75	815.75	463.77
Working Capital	6.93	7.89	6.66	17.34	8.13
Book Value Per Share	0.00	0.00	0.01	0.02	0.01
Tangible Book Value	5.44	6.24	4.47	14.38	6.07
Tangible Book Value Per Share	0.00	0.00	0.01	0.02	0.01
Machinery	0.08	0.28	0.28	0.27	0.26
Leasehold Improvements	-	0.01	0.01	0.01	0.01

Updated Aug 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q